Casey Woodring
Stock Analyst at JP Morgan
(0.70)
# 4,096
Out of 5,148 analysts
63
Total ratings
19.44%
Success rate
-13.39%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Neutral | $80 → $60 | $53.31 | +12.55% | 2 | Feb 25, 2026 | |
| GH Guardant Health | Maintains: Overweight | $120 → $130 | $92.23 | +40.95% | 3 | Feb 20, 2026 | |
| IQV IQVIA Holdings | Maintains: Overweight | $255 → $225 | $174.27 | +29.11% | 2 | Feb 6, 2026 | |
| ILMN Illumina | Maintains: Neutral | $130 → $120 | $132.89 | -9.70% | 3 | Feb 6, 2026 | |
| QGEN Qiagen | Maintains: Overweight | $55 → $60 | $48.83 | +22.88% | 5 | Feb 6, 2026 | |
| NTRA Natera | Maintains: Overweight | $250 → $260 | $200.17 | +29.89% | 3 | Dec 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $165 → $190 | $178.61 | +6.38% | 10 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $55 | $39.81 | +38.16% | 1 | Dec 15, 2025 | |
| BLLN BillionToOne | Maintains: Overweight | $150 → $145 | $78.65 | +84.36% | 2 | Dec 10, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $165 → $180 | $118.17 | +52.32% | 2 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $22 | $22.60 | -2.65% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.14 | -35.18% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $16 | $15.91 | +0.57% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $12 | $8.81 | +36.21% | 1 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $78 | $75.45 | +3.38% | 6 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $325 | $307.23 | +5.78% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $600 → $650 | $508.58 | +27.81% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1,200 → $1,285 | $1,325.09 | -3.03% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $265 → $150 | $108.27 | +38.54% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.96 | +102.70% | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $23 | $25.36 | -9.31% | 2 | Oct 31, 2023 |
Tempus AI
Feb 25, 2026
Maintains: Neutral
Price Target: $80 → $60
Current: $53.31
Upside: +12.55%
Guardant Health
Feb 20, 2026
Maintains: Overweight
Price Target: $120 → $130
Current: $92.23
Upside: +40.95%
IQVIA Holdings
Feb 6, 2026
Maintains: Overweight
Price Target: $255 → $225
Current: $174.27
Upside: +29.11%
Illumina
Feb 6, 2026
Maintains: Neutral
Price Target: $130 → $120
Current: $132.89
Upside: -9.70%
Qiagen
Feb 6, 2026
Maintains: Overweight
Price Target: $55 → $60
Current: $48.83
Upside: +22.88%
Natera
Dec 15, 2025
Maintains: Overweight
Price Target: $250 → $260
Current: $200.17
Upside: +29.89%
Charles River Laboratories International
Dec 15, 2025
Maintains: Neutral
Price Target: $165 → $190
Current: $178.61
Upside: +6.38%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $50 → $55
Current: $39.81
Upside: +38.16%
BillionToOne
Dec 10, 2025
Maintains: Overweight
Price Target: $150 → $145
Current: $78.65
Upside: +84.36%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $165 → $180
Current: $118.17
Upside: +52.32%
Nov 7, 2025
Maintains: Underweight
Price Target: $26 → $22
Current: $22.60
Upside: -2.65%
Nov 7, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $23.14
Upside: -35.18%
Nov 5, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $15.91
Upside: +0.57%
Oct 30, 2025
Downgrades: Neutral
Price Target: $14 → $12
Current: $8.81
Upside: +36.21%
Oct 22, 2025
Downgrades: Neutral
Price Target: $78
Current: $75.45
Upside: +3.38%
Oct 9, 2025
Maintains: Neutral
Price Target: $300 → $325
Current: $307.23
Upside: +5.78%
Oct 9, 2025
Maintains: Overweight
Price Target: $600 → $650
Current: $508.58
Upside: +27.81%
Oct 9, 2025
Maintains: Neutral
Price Target: $1,200 → $1,285
Current: $1,325.09
Upside: -3.03%
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $108.27
Upside: +38.54%
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.96
Upside: +102.70%
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $25.36
Upside: -9.31%